R Armentano, R G Favaloro. Show Affiliations »
Abstract
Entities: Gene
Mesh: See more » Cost-Benefit AnalysisHumansLife ExpectancyMyocardial Infarction/drug therapyStreptokinase/therapeutic useThrombolytic Therapy/economicsTissue Plasminogen Activator/therapeutic useUnited StatesValue of Life
Substances: See more » StreptokinaseTissue Plasminogen Activator
Year: 1995 PMID: 7666905
Source DB: PubMed Journal: N Engl J Med ISSN: 0028-4793 Impact factor: 91.245